WhitePaper - Digitally transformed pharmacovigilance
Why we need it and why it will take a while to become reality
Pharmacovigilance is under pressure to evolve. The necessity to change is fuelled by authority interests wanting to find better ways to protect the public, while conserving healthcare spending, as well as MAH/sponsors/CROs having to deal with soaring ICSR volumes and increasingly complex global operations.
Digital innovation seems to be the key to deliver major change, to harness technology advancements and the radically increasing data volumes - across clinical trials to real-world sources.
Download this Whitepaper to learn:
- The challenge to evolve pharmacovigilance
- The four pillars where transformation is expected
- 4 Key barriers for industry adopting digital innovation in PV